Metadata
- Name
- Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT00803842
- Description
- A side effect occurring in a majority of patients taking erlotinib (Tarceva®) consists of a
skin rash. Sometimes, symptoms associated with the rash necessitate erlotinib dose reduction
or discontinuation. Some physicians have successfully treated the erlotinib-induced rash with
doxycycline. At the same time, it has been observed that in patients who develop the
erlotinib rash, the cancers respond better to erlotinib treatment. This research study is
designed to determine how well doxycycline treats the erlotinib rash and whether doxycycline
affects the blood levels of erlotinib. - Data or Study Types
- clinical trial
- Keywords
- erlotinib, supportive care, rash
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2008
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT00803842
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT00803842